728 filings
Page 10 of 37
8-K
KA
Kineta Inc
27 Oct 22
Kineta to Present Pre-clinical Data on VISTA and CD27 Programs at SITC 2022 Annual Meeting
7:13am
425
KA
Kineta Inc
26 Oct 22
Business combination disclosure
5:17pm
8-K
KA
Kineta Inc
26 Oct 22
Regulation FD Disclosure
5:14pm
425
KA
Kineta Inc
26 Oct 22
Business combination disclosure
5:10pm
8-K
KA
Kineta Inc
26 Oct 22
Regulation FD Disclosure
5:08pm
S-4/A
KA
Kineta Inc
Registration of securities issued in business combination transactions (amended)
24 Oct 22
9:14am
425
KA
Kineta Inc
24 Oct 22
Business combination disclosure
8:00am
8-K
KA
Kineta Inc
24 Oct 22
Entry into a Material Definitive Agreement
7:59am
CORRESP
KA
Kineta Inc
24 Oct 22
Correspondence with SEC
12:00am
425
KA
Kineta Inc
17 Oct 22
Business combination disclosure
4:03pm
8-K
KA
Kineta Inc
17 Oct 22
Clinical trial anticipated to begin in late 2022
4:02pm
UPLOAD
KA
Kineta Inc
14 Oct 22
Letter from SEC
12:00am
425
KA
Kineta Inc
13 Oct 22
Business combination disclosure
4:03pm
8-K
KA
Kineta Inc
13 Oct 22
Kineta to Present Anti-CD27 Agonist Preclinical Program at AACR Conference on Tumor Immunology and Immunotherapy
4:01pm
425
KA
Kineta Inc
11 Oct 22
Business combination disclosure
8:02am
8-K
KA
Kineta Inc
11 Oct 22
Kineta Announces Participation in Upcoming October 2022 Investor Conferences
8:00am
425
KA
Kineta Inc
4 Oct 22
Business combination disclosure
4:04pm
8-K
KA
Kineta Inc
4 Oct 22
Kineta Appoints Keith Baker as Chief Financial Officer
4:01pm
S-4/A
KA
Kineta Inc
Registration of securities issued in business combination transactions (amended)
3 Oct 22
4:54pm
CORRESP
KA
Kineta Inc
3 Oct 22
Correspondence with SEC
12:00am